comparemela.com

Latest Breaking News On - Samantha gaspar - Page 4 : comparemela.com

Halozyme Announces Roche Receives European Commission Approval of Tecentriq® SC with ENHANZE® Representing the EU's First Subcutaneous PD-(L)1 Cancer Immunotherapy for Multiple Cancer Types

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Roche received European Commission (EC) marketing authorization of.

San-diego
California
United-states
Helen-torley
Samantha-gaspar
Eli-lilly
Corporate-communications
Acumen-pharmaceuticals
Genentech
Exchange-commission
Prnewswire-halozyme-therapeutics-inc
European-union

Halozyme Announces Takeda Receives FDA Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Takeda received U.S. Food and Drug Administration (FDA) approval.

San-diego
California
United-states
Samantha-gaspar
Eli-lilly
Helen-torley
Prnewswire-halozyme-therapeutics-inc
Bristol-myers-squibb
Exchange-commission
Corporate-communications
Acumen-pharmaceuticals
Teva-pharmaceuticals

Halozyme to Host Investor Business Forum and Long-Term Outlook Call

SAN DIEGO, Jan. 12, 2024 /PRNewswire/  Halozyme Therapeutics, Inc. today announced that it will host an Investor Business Forum and Long-Term Outlook Call on Wednesday, January 17, 2024 at 5:30.

San-diego
California
United-states
Samantha-gaspar
Mark-snyder
Helen-torley
Eli-lilly
Nicole-labrosse
Twitter
Teva-pharmaceuticals
Pfizer
Bristol-myers-squibb

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.